NYSE$TMO

Thermo Fisher Scientific Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Thermo Fisher's financial performance was reported for Q3 2023, marked by revenue decline but strong EPS growth.

Thermo Fisher Scientific reported a slight decrease in revenue for Q3 2023, but demonstrated strong earnings per share (EPS) growth. The company is managing macroeconomic challenges through its PPI Business System and continues to invest in future growth, including the acquisition of Olink Holding AB.

  • Third quarter revenue was $10.57 billion, a 1% decrease compared to the same quarter last year, with a core organic revenue growth of 1%.
  • GAAP diluted earnings per share (EPS) for the third quarter was $4.42, a 17% increase compared to the previous year, driven by operating margin expansion.
  • Adjusted EPS for the third quarter was $5.69, a 12% increase compared to the prior year, driven by adjusted operating margin expansion.
  • Thermo Fisher announced an agreement to acquire Olink Holding AB for approximately $3.1 billion, to enhance proteomic solutions.

Headline financials

Total Revenue

$10.6B

Previous: $10.7B-1.0%
EPS (adj)

$5.69

Previous: $5.08+12.0%
Adjusted Operating Margin

24.2%

No prior period
GAAP Operating Margin

17.6%

No prior period
Capital Expenditures

-$1.07B

Previous: -$1.69B+36.6%
Free Cash Flow

$621M

Previous: -$195M+418.5%
Net Income

$1.7B

Previous: $1.5B+13.2%
Operating Income

$1.86B

Previous: $1.71B+9.0%
Gross Profit

$4.43B

Previous: $4.43B-0.0%
Cash & Equivalents

$6.15B

Previous: $2.92B+110.7%
Total Assets

$97.1B

Previous: $90.5B+7.2%
Stock-Based Comp

$67M

Previous: $77M-13.0%

Revenue & EPS history

Thermo Fisher · Revenue · Quarterly

$10.6B

Q3 2023-1%vs Q3 2022
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Thermo Fisher · $11B total across 4 segments · Q3 2023

  • Lab Products & Biopharma
    $5.73B+2.6%
  • Life Sciences Solutions
    $2.43B-17.9%
  • Analytical Instruments
    $1.75B+8.2%
  • Specialty Diagnostics
    $1.08B+1.7%

Forward guidance

Thermo Fisher is revising its revenue and adjusted EPS guidance for the full year 2023 due to the current macroeconomic environment.

Tailwinds

  • The company expects 2023 revenue to be $42.7 billion.
  • Core organic revenue growth is projected to be 1% for 2023.
  • Adjusted EPS is expected to be $21.50 for the full year.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

+0.5%

Avg return

Earnings day

+0.4%

Avg return

5 days after

-0.1%

Avg return

30 days after

53%

39 / 73 earnings

Positive

+9.9%

Q2 2012

Best reaction

-7.8%

Q2 2011

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.6%-8.5%-12.7%
Q4 2025-4.6%-6.2%-14.3%
Q3 2025+1.5%+1.0%+5.3%
Q2 2025+3.2%+5.8%+6.3%
Q1 2025-0.7%-3.1%-9.4%
Q4 2024+6.8%+2.2%-6.9%
Q3 2024-4.9%-5.8%-12.5%
Q2 2024+7.7%+9.4%+9.8%
Q1 2024-0.5%+0.4%+1.6%
Q4 2023-2.6%-2.7%+1.6%
Q3 2023-3.9%-5.3%+7.1%
Q2 2023-1.9%-3.9%-5.1%
Q1 2023-1.0%+0.0%-4.8%
Q4 2022+2.9%+1.0%-1.9%
Q3 2022-3.2%-0.1%+7.1%
Q2 2022+2.8%+0.7%-3.1%
Q1 2022+6.2%+5.0%+10.0%
Q4 2021+0.1%-1.2%-7.9%
Q3 2021+1.9%+4.4%+5.0%
Q2 2021+0.7%+0.6%+3.4%
Q1 2021-3.2%-4.2%-3.4%
Q4 2020+1.7%-3.4%-11.5%
Q3 2020+3.6%+3.7%-3.1%
Q2 2020+1.8%+2.6%+6.3%
Q1 2020+0.3%+7.2%+6.5%
Q4 2019-6.2%-2.4%-12.9%
Q3 2019+4.4%+6.7%+9.5%
Q2 2019-1.0%-1.6%-8.3%
Q1 2019+2.1%+3.3%+3.0%
Q4 2018+3.7%+2.8%+11.5%
Q3 2018+3.1%+2.2%+5.2%
Q2 2018+5.7%+4.2%+6.0%
Q1 2018+0.3%-1.3%+0.2%
Q4 2017+3.6%-2.9%-3.8%
Q3 2017+3.1%-1.2%-0.4%
Q2 2017-2.7%-2.6%-1.6%
Q1 2017+5.0%+4.9%+9.2%
Q4 2016+6.7%+5.7%+11.1%
Q3 2016-0.6%-1.4%-2.6%
Q2 2016-0.0%-1.5%-4.1%
Q1 2016-2.0%
Q4 2015-2.8%
Q3 2015-3.6%
Q2 2015+3.0%
Q1 2015-3.6%
Q4 2014+0.7%
Q3 2014-1.7%
Q2 2014+2.0%
Q1 2014-4.1%
Q4 2013+3.0%
Q3 2013+1.3%
Q2 2013+1.9%
Q1 2013-0.6%
Q4 2012+6.2%
Q3 2012+7.1%
Q2 2012+9.9%
Q1 2012+4.1%
Q4 2011-0.1%
Q4 2010-0.1%
Q3 2011-1.5%
Q2 2011-7.8%
Q1 2011-0.2%
Q3 2010-1.7%
Q2 2010+1.0%
Q1 2009-6.2%
Q1 2010+0.2%
Q4 2007-1.3%
Q4 2009-1.3%
Q3 2008-2.8%
Q3 2009-2.8%
Q2 2008+0.5%
Q2 2009+0.5%
Q4 2008+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro